147 related articles for article (PubMed ID: 37185426)
21. Mutational analyses of epidermal growth factor receptor and downstream pathways in adrenocortical carcinoma.
Hermsen IG; Haak HR; de Krijger RR; Kerkhofs TM; Feelders RA; de Herder WW; Wilmink H; Smit JW; Gelderblom H; de Miranda NF; van Eijk R; van Wezel T; Morreau H
Eur J Endocrinol; 2013 Jul; 169(1):51-8. PubMed ID: 23585556
[TBL] [Abstract][Full Text] [Related]
22. Adrenocortical cancer: mortality, hormone secretion, proliferation and urine steroids - experience from a single centre spanning three decades.
Calissendorff J; Calissendorff F; Falhammar H
BMC Endocr Disord; 2016 Mar; 16():15. PubMed ID: 26984275
[TBL] [Abstract][Full Text] [Related]
23. Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma.
Duregon E; Molinaro L; Volante M; Ventura L; Righi L; Bolla S; Terzolo M; Sapino A; Papotti MG
Mod Pathol; 2014 Sep; 27(9):1246-54. PubMed ID: 24434900
[TBL] [Abstract][Full Text] [Related]
24. Expression of the zinc-finger transcription factor Snail in adrenocortical carcinoma is associated with decreased survival.
Waldmann J; Feldmann G; Slater EP; Langer P; Buchholz M; Ramaswamy A; Saeger W; Rothmund M; Fendrich V
Br J Cancer; 2008 Dec; 99(11):1900-7. PubMed ID: 19018264
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations.
Duregon E; Rapa I; Votta A; Giorcelli J; Daffara F; Terzolo M; Scagliotti GV; Volante M; Papotti M
Hum Pathol; 2014 Aug; 45(8):1555-62. PubMed ID: 24890943
[TBL] [Abstract][Full Text] [Related]
26. [Multifactorial assessment of prognostic features of adrenocortical cancer].
Porubayeva EE; Pachuashvili NV; Urusova LS
Arkh Patol; 2022; 84(5):20-27. PubMed ID: 36178218
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas.
Morimoto R; Satoh F; Murakami O; Suzuki T; Abe T; Tanemoto M; Abe M; Uruno A; Ishidoya S; Arai Y; Takahashi K; Sasano H; Ito S
Endocr J; 2008 Mar; 55(1):49-55. PubMed ID: 18187873
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis.
Yamazaki Y; Nakamura Y; Shibahara Y; Konosu-Fukaya S; Sato N; Kubota-Nakayama F; Oki Y; Baba S; Midorikawa S; Morimoto R; Satoh F; Sasano H
Hum Pathol; 2016 Jul; 53():41-50. PubMed ID: 26980031
[TBL] [Abstract][Full Text] [Related]
29. Association between preoperative serum albumin and prognosis in patients with adrenocortical carcinoma after primary resection: a retrospective study.
Zhang F; Liu Z; Liang J; Liu S; Wu K; Zhang F; Zhou C; Lu Y; Zhu Y; Wang X
BMC Cancer; 2021 Aug; 21(1):961. PubMed ID: 34445989
[TBL] [Abstract][Full Text] [Related]
30. Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma.
Poli G; Ruggiero C; Cantini G; Canu L; Baroni G; Armignacco R; Jouinot A; Santi R; Ercolino T; Ragazzon B; Assie G; Mannelli M; Nesi G; Lalli E; Luconi M
J Clin Endocrinol Metab; 2019 May; 104(5):1712-1724. PubMed ID: 30476173
[TBL] [Abstract][Full Text] [Related]
31. Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection.
Beuschlein F; Weigel J; Saeger W; Kroiss M; Wild V; Daffara F; Libé R; Ardito A; Al Ghuzlan A; Quinkler M; Oßwald A; Ronchi CL; de Krijger R; Feelders RA; Waldmann J; Willenberg HS; Deutschbein T; Stell A; Reincke M; Papotti M; Baudin E; Tissier F; Haak HR; Loli P; Terzolo M; Allolio B; Müller HH; Fassnacht M
J Clin Endocrinol Metab; 2015 Mar; 100(3):841-9. PubMed ID: 25559399
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological Features Associated With the Prognosis of Patients With Adrenal Cortical Carcinoma: Usefulness of the Ki-67 Index.
Choi YM; Kwon H; Jeon MJ; Sung TY; Hong SJ; Kim TY; Kim WB; Shong YK; Lee JL; Song DE; Kim WG
Medicine (Baltimore); 2016 May; 95(21):e3736. PubMed ID: 27227935
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex.
Szajerka A; Dziegiel P; Szajerka T; Zabel M; Winowski J; Grzebieniak Z
Anticancer Res; 2008; 28(5B):2959-65. PubMed ID: 19031940
[TBL] [Abstract][Full Text] [Related]
34. Adrenocortical Cancer: A 20-Year Experience of a Single Referral Center in Prognosis and Outcomes.
Parianos C; Kyriakopoulos G; Kostakis ID; Nasiri-Ansari N; Aggeli C; Dimitriadi A; Angelousi A; Papavassiliou AG; Kaltsas GA; Zografos G; Kassi E
Horm Metab Res; 2021 Nov; 53(11):709-716. PubMed ID: 34740271
[TBL] [Abstract][Full Text] [Related]
35. Impact of standardised reporting in adrenocortical carcinoma: a single centre clinicopathological review.
Advani A; Vaikkakara S; Gill MS; Arun CS; Pearce SH; Ball SG; James RA; Lennard TW; Bliss RD; Quinton R; Johnson SJ
J Clin Pathol; 2008 Aug; 61(8):939-44. PubMed ID: 18515402
[TBL] [Abstract][Full Text] [Related]
36. A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease.
Asare EA; Wang TS; Winchester DP; Mallin K; Kebebew E; Sturgeon C
Surgery; 2014 Dec; 156(6):1378-85; discussion 1385-6. PubMed ID: 25456914
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological features, biochemical and molecular markers in 5 patients with adrenocortical carcinoma.
Kouyama R; Hiraishi K; Sugiyama T; Izumiyama H; Yoshimoto T; Akashi T; Kihara K; Homma K; Shibata H; Hirata Y
Endocr J; 2011; 58(7):527-34. PubMed ID: 21521927
[TBL] [Abstract][Full Text] [Related]
38. Feminizing Adrenocortical Carcinoma: The Source of Estrogen Production and the Role of Adrenal-Gonadal Dedifferentiation.
Wu L; Xie J; Jiang L; Su T; Ye L; Zhou W; Jiang Y; Zhang C; Ning G; Wang W
J Clin Endocrinol Metab; 2018 Oct; 103(10):3706-3713. PubMed ID: 30053001
[TBL] [Abstract][Full Text] [Related]
39. Is there a role for epithelial-mesenchymal transition in adrenocortical tumors?
Bulzico D; Faria PAS; Maia CB; de Paula MP; Torres DC; Ferreira GM; Pires BRB; Hassan R; Abdelhay E; Vaisman M; Vieira Neto L
Endocrine; 2017 Nov; 58(2):276-288. PubMed ID: 28887601
[TBL] [Abstract][Full Text] [Related]
40. Adrenocortical Carcinoma in Children: A Clinicopathological Analysis of 41 Patients at the Mayo Clinic from 1950 to 2017.
Gupta N; Rivera M; Novotny P; Rodriguez V; Bancos I; Lteif A
Horm Res Paediatr; 2018; 90(1):8-18. PubMed ID: 29804118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
